The prognostic value and overexpression of cyclin A is correlated with gene amplification of both cyclin A and cyclin E in breast cancer patient

Cellular Oncology

Volumn 28, Issue 3, 2006, Pages 107-116

  Husdal, A ^a,b   Bukholm, G ^a,b   Bukholm, I R K ^a,b  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Cyclins; Gene amplification; Immunohistochemistry; Patient survival

Indexed keywords

CYCLIN A; CYCLIN B1; CYCLIN C; CYCLIN D1; CYCLIN D3; CYCLIN E; CYCLIN H; CYCLINE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CELL CYCLE REGULATION; CONTROLLED STUDY; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

BREAST NEOPLASMS; CYCLIN A; CYCLIN E; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS;

EID: 33745698050     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. S. Aaltomaa, M. Eskelinen and P. Lipponen, Expression of cyclin A and D proteins in prostate cancer and their relation to clinopathological variables and patient survival, Prostate 38 (1999), 175-182.
2. S. Aaltomaa, P. Lipponen, M. Ala-Opas, M. Eskelinen, K. Syrjanen and V.M. Kosma, Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival, Br. J. Cancer 80 (1999), 2001-2007.
3. S. Akoulitchev, S. Chuikov and D. Reinberg, TFIIH is negatively regulated by cdk8-containing mediator complexes, Nature 407 (2000), 102-106.
4. J.M. Blanchard, Cyclin A2 transcriptional regulation: modulation of cell cycle control at the G1/S transition by peripheral cues, Biochem. Pharmacol. 60 (2000), 1179-1184.
5. M.F. Buckley, K.J. Sweeney, J.A. Hamilton, R.L. Sini, D.L. Manning, R.I. Nicholson, A. deFazio, C.K. Watts, E.A. Musgrove and R.L. Sutherland, Expression and amplification of cyclin genes in human breast cancer, Oncogene 8 (1993), 2127-2133.
6. I.R. Bukholm, G. Bukholm and J.M. Nesland, Coexpression of cyclin A and beta-catenin and survival in breast cancer patients, Int. J. Cancer 94 (2001), 148-149.
7. I.R. Bukholm, G. Bukholm and J.M. Nesland, Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas, Int. J. Cancer 93 (2001), 283-287.
8. I.R. Bukholm, A. Husdal, J.M. Nesland, A. Langerod and G. Bukholm, Overexpression of cyclin A overrides the effect of p53 alterations in breast cancer patients with long follow-up time, Breast Cancer Res. Treat. 80 (2003), 199-206.
9. P.J. van Diest, R.J. Michalides, L. Jannink, V, van, d., H.L. Peterse, J.S. de Jong, C.J. Meijer and J.P. Baak, Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value, Am. J. Pathol. 150 (1997), 705-711.
10. Y. Dobashi, M. Shoji, S.X. Jiang, M. Kobayashi, Y. Kawakubo and T. Kameya, Active cyclin A-CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas, Am. J. Pathol. 153 (1998), 963-972.
11. Y. Dobashi, M. Shoji, S.X. Jiang, M. Kobayashi, Y. Kawakubo and T. Kameya, Active cyclin A-CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas, Am. J. Pathol. 153 (1998), 963-972.
12. N. Dyson, The regulation of E2F by pRB-family proteins, Genes Dev. 12 (1998), 2245-2262.
13. V.A. Florenes, G.M. Maelandsmo, R. Faye, J.M. Nesland and R. Holm, Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome, J. Pathol. 195 (2001), 530-536.
14. S. Fredersdorf, J. Burns, A.M. Milne, G. Packham, L. Fallis, C.E. Gillett, J.A. Royds, D. Peston, P.A. Hall, A.M. Hanby, D.M. Barnes et al., High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancer, Proc. Natl. Acad. Sci. USA 94 (1997), 6380-6385.
15. S. Garrett, W.A. Barton, R. Knights, P. Jin, D.O. Morgan and R.P. Fisher, Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop, Mol. Cell Biol. 21 (2001), 88-99.
16. D. Hanahan and R.A. Weinberg, The hallmarks of cancer, Cell 100 (2000), 57-70.
17. K. Handa, M. Yamakawa, H. Takeda, S. Kimura and T. Takahashi, Expression of cell cycle markers in colorectal carcinoma: superiority of cyclin A as an indicator of poor prognosis, Int. J. Cancer 84 (1999), 225-233.
18. C.A. Heid, J. Stevens, K.J. Livak and P.M. Williams, Real time quantitative PCR, Genome Res. 6 (1996), 986-994.
19. C.J. Hengartner, V.E. Myer, S.M. Liao, C.J. Wilson, S.S. Koh and R.A. Young, Temporal regulation of RNA polymerase II by Srb10 and Kin28 cyclin-dependent kinases, Mol. Cell 2 (1998), 43-53.
20. A. Kallioniemi, O.P. Kallioniemi, J. Piper, M. Tanner, T. Stokke, L. Chen, H.S. Smith, D. Pinkel, J.W. Gray and F.M. Waldman, Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization, Proc. Natl. Acad. Sci. USA 91 (1994), 2156-2160.
21. F.S. Kenny, R. Hui, E.A. Musgrove, J.M. Gee, R.W. Blamey, R.I. Nicholson, R.L. Sutherland and J.F. Robertson, Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer, Clin. Cancer Res. 5 (1999), 2069-2076.
22. K. Keyomarsi, N. O'Leary, G. Molnar, E. Lees, H.J. Fingert and A.B. Pardee, Cyclin E, a potential prognostic marker for breast cancer, Cancer Res. 54 (1994), 380-385.
23. K. Kitahara, W. Yasui, H. Kuniyasu, H. Yokozaki, Y. Akama, S. Yunotani, T. Hisatsugu and E. Tahara, Concurrent amplification of cyclin E and CDK2 genes in colorectal carcinomas, Int. J. Cancer 62 (1995), 25-28.
24. D. Korenaga, F. Takesue, M. Yasuda, M. Honda, T. Nozoe and S. Inutsuka, The relationship between cyclin B1 overexpression and lymph node metastasis in human colorectal cancer, Surgery 131 (2002), S114-S120.
25. G. Landberg and G. Roos, The cell cycle in breast cancer, APMIS 105 (1997), 575-589.
26. P. Leopold and P.H. O'Farrell, An evolutionarily conserved cyclin homolog from Drosophila rescues yeast deficient in G1 cyclins, Cell 66 (1991), 1207-1216.
27. D.J. Lew, V. Dulic and S.I. Reed, Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast, Cell 66 (1991), 1197-1206.
28. H. Li, J.M. Lahti, M. Valentine, M. Saito, S.I. Reed, A.T. Look and V.J. Kidd, Molecular cloning and chromosomal localization of the human cyclin C (CCNC) and cyclin E (CCNE) genes: deletion of the CCNC gene in human tumors, Genomics 32 (1996), 253-259.
29. M. Marone, G. Scambia, C. Giannitelli, G. Ferrandina, V. Masciullo, A. Bellacosa, P. Edetti-Panici and S. Mancuso, Analysis of cyclin E and CDK2 in ovarian cancer: gene amplification and RNA overexpression, Int. J. Cancer 75 (1998), 34-39.
30. R. Michalides, P. Hageman, H. van Tinteren, L. Houben, E. Wientjens, R. Klompmaker and J. Peters, A clinicopathological study on overexpression of cyclin D1 and p53 in a series of 248 patients with operable breast cancer, Br. J. Cancer 73 (1996), 728-734.
31. A.W. Murray, Creative blocks: cell-cycle checkpoints and feedback controls, Nature 359 (1992), 599-604.
32. N.H. Nielsen, C. Arnerlov, S.O. Emdin and G. Landberg, Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status, Br. J. Cancer 74 (1996), 874-880.
33. P. Platzer, M.B. Upender, K. Wilson, J. Willis, J. Lutterbaugh, A. Nosrati, J.K. Willson, D. Mack, T. Ried and S. Markowitz, Silence of chromosomal amplifications in colon cancer, Cancer Res. 62 (2002), 1134-1138.
34. P. Poikonen, J. Sjostrom, R.M. Amini, K. Villman, J. Ahlgren and C. Blomqvist, Cyclin A as a marker for prognosis and chemotherapy response in advanced breast cancer, Br. J. Cancer 93 (2005), 515-519.
35. P.L. Porter, K.E. Malone, P.J. Heagerty, G.M. Alexander, L.A. Gatti, E.J. Firpo, J.R. Daling and J.M. Roberts, Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients, Nat. Med. 3 (1997), 222-225.
36. C. Sandhu and J. Slingerland, Deregulation of the cell cycle in cancer, Cancer Detect. Prev. 24 (2000), 107-118.
37. P. Szepetowski, D. Perucca-Lostanlen and P. Gaudray. Mapping genes according to their amplification status in tumor cells: contribution to the map of 11q13, Genomics 16 (1993), 745-750.
38. Y. Takano, Y. Kato, P.J. van Diest, M. Masuda, H. Mitomi and I. Okayasu, Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases, Am. J. Pathol. 156 (2000), 585-594.
39. U. Ueberham, A. Hessel and T. Arendt, Cyclin C expression is involved in the pathogenesis of Alzheimer's disease, Neurobiol. Aging 24 (2003), 427-435.
40. C. Vaziri, S. Saxena, Y. Jeon, C. Lee, K. Murata, Y. Machida, N. Wagle, D.S. Hwang and A. Dutta, A p53-dependent checkpoint pathway prevents rereplication, Mol. Cell 11 (2003), 997-1008.
41. M. Volm, R. Koomagi, J. Mattern and G. Stammler, Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas, Br. J. Cancer 75 (1997), 1774-1778.
42. Y. Yin, M.A. Tainsky, F.Z. Bischoff, L.C. Strong and G.M. Wahl, Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles, Cell 70 (1992), 937-948.